News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 ‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II Michael O'Riordan October 26, 2023
News Conference News TCT 2023 Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out Michael O'Riordan October 25, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023